Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Jakob Dörler"'
Autor:
Moritz Messner, Santhosh Kumar Ghadge, Valentina Goetsch, Andreas Wimmer, Jakob Dörler, Gerhard Pölzl, Marc-Michael Zaruba
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0196739 (2018)
Mutations in the LMNA gene are a common cause (6-8%) of dilated cardiomyopathy (DCM) leading to heart failure, a growing health care problem worldwide. The premature aging disease Hutchinson-Gilford syndrome (HGPS) is also caused by defined mutations
Externí odkaz:
https://doaj.org/article/954ee0c380b24b74b1917793913c564d
Autor:
Michael Edlinger, Dirk von Lewinski, Jakob Dörler, Matthias Frick, Kurt Huber, Thomas Stefenelli, Günter Christ, Johann Sipötz, Axel Bauer, Hannes Alber, Matthias Hasun, Rudolf Berger, Uta C. Hoppe, Clemens Steinwender, Elisabeth Laßnig, Franz Weidinger, Franz X. Roithinger, Peter Siostrzonek, Anna Rab, Gudrun Lamm, Herwig Schuchlenz
Publikováno v:
Cardiovasc Diagn Ther
BACKGROUND: Randomised controlled trials have shown diverse results for radial access in patients undergoing primary percutaneous coronary intervention (PPCI). Moreover, it is questionable whether radial access improves outcome in patients with cardi
Autor:
Stefan Aschauer, Nicolas Verheyen, Roland Schwarz, Diana Bonderman, Julia Mascherbauer, Thomas Weber, Renate Kain, Andreas A. Kammerlander, Agnes Mayr, Marc Michael Zaruba, Christian Ebner, Peter P. Rainer, Klemens Ablasser, Christian Nitsche, Matthias Schneider, Roza Badr Eslam, Gerhard Pölzl, Martin Hülsmann, Alexander Kroiss, Susanne Reiter-Malmqvist, Michaela Auer-Grumbach, Jakob Dörler, Matthias Koschutnik, Hermine Agis, Christina Binder, Franz Duca, Marcus Hacker
Publikováno v:
Wiener Klinische Wochenschrift
SummaryThe prevalence and significance of cardiac amyloidosis have been considerably underestimated in the past; however, the number of patients diagnosed with cardiac amyloidosis has increased significantly recently due to growing awareness of the d
Autor:
Jutta Bergler-Klein, Peter P. Rainer, Markus Wallner, Marc-Michael Zaruba, Jakob Dörler, Armin Böhmer, Tamara Buchacher, Maria Frey, Christopher Adlbrecht, Rupert Bartsch, Mariann Gyöngyösi, Ursula-Maria Fürst
Publikováno v:
Wiener klinische Wochenschrift. 134(17-18)
SummarySurvival in cancer is continuously improving due to evolving oncological treatment. Therefore, cardiovascular short-term and long-term side effects gain crucial importance for overall outcome. Cardiotoxicity not only presents as heart failure,
Autor:
Marc J. Claeys, Christian M. Matter, Jakob Dörler, Franz Weidinger, Dragana Radovanovic, Uwe Zeymer, Thomas F. Lüscher, Johan Wouter Jukema, Leonardo De Luca, Paul Erne
Publikováno v:
European Heart Journal-Cardiovascular Pharmacotherapy, 7(2), 94-103. OXFORD UNIV PRESS
European heart journal : cardiovascular pharmacotheraphy
European Heart Journal — Cardiovascular Pharmacotherapy
European heart journal : cardiovascular pharmacotheraphy
European Heart Journal — Cardiovascular Pharmacotherapy
Aims Among acute coronary syndromes (ACS), ST-segment elevation myocardial infarction (STEMI) has the most severe early clinical course. Recent randomized clinical trials have demonstrated that novel antithrombotic therapies improve in-hospital outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dd40ed994d0c1c4dd30be4e61719469
https://hdl.handle.net/1887/3274107
https://hdl.handle.net/1887/3274107
Autor:
Maria Wanitschek, Hanno Ulmer, Jakob Dörler, Michael Edlinger, Ewout W. Steyerberg, Hannes Alber, Ben Van Calster
Publikováno v:
International Journal of Cardiology, 267, 8-12
International Journal of Cardiology, 267, 8-12. Elsevier Ireland Ltd
International Journal of Cardiology
International Journal of Cardiology, 267, 8-12. Elsevier Ireland Ltd
International Journal of Cardiology
© 2018 Elsevier B.V. Background: The extent of coronary artery disease (CAD) is relevant for the evaluation and the choice of treatment of patients and consists of the severity of stenoses and their distribution within the coronary tree. Diagnosis i
Autor:
Fabian Barbieri, Jakob Dörler, M M Zaruba, Gudrun Feuchtner, Silvana Müller, Gerhard Pölzl, Andrea Klauser, Christoph Beyer, Leo Pölzl, Stefan Rauch, Philipp Burghard, Eric E. Williamson, Fabian Plank, Christian-Ekkehardt Langer, Wilfried Schgoer
Publikováno v:
European radiology. 28(12)
To evaluate right ventricle (RV) function by coronary computed tomography angiography (CTA) using a novel automated three-dimensional (3D) RV volume segmentation tool in comparison with clinical reference modalities. Twenty-six patients with severe e
Autor:
Elske Ammenwerth, Robert Modre-Osprian, Bettina Fetz, Susanne Gstrein, Susanne Krestan, Jakob Dörler, Peter Kastner, Stefan Welte, Clemens Rissbacher, Gerhard Pölzl
BACKGROUND Heart failure is a major health problem associated with frequent hospital admissions. HerzMobil Tirol is a multidisciplinary postdischarge disease management program for heart failure patients to improve quality of life, prevent readmissio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3b9c8bc20f62c400b3a59a6e1164a60
https://doi.org/10.2196/preprints.9936
https://doi.org/10.2196/preprints.9936
Autor:
Peter Kastner, Stefan Welte, Susanne Gstrein, Elske Ammenwerth, Bettina Fetz, Susanne Krestan, Jakob Dörler, Robert Modre-Osprian, Clemens Rissbacher, Gerhard Pölzl
Publikováno v:
JMIR Cardio
Background: Heart failure is a major health problem associated with frequent hospital admissions. HerzMobil Tirol is a multidisciplinary postdischarge disease management program for heart failure patients to improve quality of life, prevent readmissi
Autor:
Matthias Hasun, Jakob Dörler, Michael Edlinger, Hannes Alber, Dirk Von Lewinski, Bernd Eber, Franz Xaver Roithinger, Rudolf Berger, Peter Siostrzonek, Georg Grimm, Werner Benzer, Wilfried Wintersteller, Kurt Huber, Herwig Schuchlenz, Franz Weidinger, K. Kerschner, K. Saleh, C. Steinwender, M. Juhasz, J. Rieschl, A. Buberl, M. Pilshofer, J. Auer, K. Kremser, F. Gratze, G. Zenker, H. Schuchlenz, W. Weihs, O. Pachinger, A. Rab, G. Fleischmann, T. Ovsenk, J. Sykora, H. Wallner, K. Laubreiter, S. Buesel, R. Hoeppel, R. Kofler, L. Kaltenbach, H. Ulmer, G. Christ, G. Norman, H. Weber, E. Lassnig, E. Maurer, E. Piackova, A. Geppert, M. Derntl
Publikováno v:
The American journal of cardiology. 120(12)
Randomized controlled trials have shown conflicting results regarding the outcome of bivalirudin in primary percutaneous coronary intervention (PPCI). The aim of this study was to evaluate the in-hospital outcomes of patients receiving heparin or biv